Global Generic Pharmaceuticals Industry Report

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

The Generic Drugs Market: 2015 - 2030 - Opportunities, Challenges, Strategies & Forecasts

The Generic Drugs Market: 2015 - 2030 - Opportunities, Challenges, Strategies & Forecasts

  • $ 2 500
  • Industry report
  • by SNS Telecom
  • February 2015
  • 249 pages

A generic drug is a pharmaceutical product, usually intended to be interchangeable with an innovator product, that is manufactured without a license from the innovator company and marketed after the expiry date of the patent or other exclusive rights. Already prevalent in the U.S., Europe and much of ...

Industries: Generic Drug | Countries: World, Europe, Japan, South Korea, India, Asia, United States, North America, Canada, China, Africa, Netherlands, Saudi Arabia, South Africa

2015 Market Research Report on Global Biologics and Biosimilars Industry

2015 Market Research Report on Global Biologics and Biosimilars Industry

  • $ 2 600
  • Industry report
  • by QY Research Group
  • February 2015
  • 171 pages

Summary 2015 Market Research Report on Global Biologics and Biosimilars Industryis a professional and depth research report on Global Biologics and Biosimilars industry For overview analysis, the report introduces Biologics and Biosimilars basic information including definition, classification, application, ...

Industries: Generic Drug | Countries: World, China

World Generic Markets 05 JANUARY 2015

World Generic Markets 05 JANUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • January 2015
  • 20 pages

Industry Trend Analysis - National And International Legislation To Mould Generic Industry In 2015 Industry Brief - Teva Launches Erlotinib In Canada Industry Brief - Par Adds Name To Trokendi XR Patent Challengers Industry Brief - Teva, Actavis Launch Celecoxib In US Industry Brief - Mylan Gains Tentative ...

Industries: Generic Drug | Countries: World, United States

Generic Pharmaceuticals Global - Industry Report

Generic Pharmaceuticals Global - Industry Report

  • $ 1 668
  • Industry report
  • by Plimsoll Publishing Ltd UK
  • January 2015
  • 200 pages

Plimsoll's GENERIC PHARMACEUTICALS (Global) analysis is the most definitive and accurate study of the GENERIC PHARMACEUTICALS (Global) sector in 2013. The report is split into two sections and uses both a written and graphical analysis - analysing the 200 largest GENERIC PHARMACEUTICALS (Global) companies. ...

Industries: Generic Drug | Countries: World

Fesoterodine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Fesoterodine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • by Ark Patent Intelligence
  • January 2015

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Generic Drug | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World

Frovatriptan  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Frovatriptan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • by Ark Patent Intelligence
  • January 2015

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Generic Drug | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World

Galantamine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Galantamine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • by Ark Patent Intelligence
  • January 2015

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Generic Drug | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World

Ibandronic Acid  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Ibandronic Acid - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • by Ark Patent Intelligence
  • January 2015

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Generic Drug | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World

Lasofoxifene  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Lasofoxifene - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • by Ark Patent Intelligence
  • January 2015

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Generic Drug | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World

Pitavastatin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Pitavastatin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • by Ark Patent Intelligence
  • January 2015

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Generic Drug | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.